1st Quarter - Report

PRIME THERAPEUTICS for PRIME THERAPEUTICS

Firm
Client
Income
—
Expenses
$160,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Health care cost control Essential Health Benefits

LobbyistCovered position, as disclosed
STACEY FAHRNER —

Contacted: SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Pharmacy PHA

Express Scripts Medco Merger Pharmacy Benefit Manager Audit Reform (S. 1058) Pharmacy anti-trust (H.R. 1946)

LobbyistCovered position, as disclosed
STACEY FAHRNER —

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1058 (112th), H.R. 1946 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.